These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29936685)

  • 21. Leveraging benefit design for better diabetes self-management and A1C control.
    Agiro A; Xie Y; Bowman K; DeVries A
    Am J Manag Care; 2018 Feb; 24(2):e30-e36. PubMed ID: 29461848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stratifying healthcare costs using the Diabetes Complication Severity Index.
    Wu CX; Tan WS; Toh MP; Heng BH
    J Diabetes Complications; 2012; 26(2):107-12. PubMed ID: 22465400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study.
    Mody R; Huang Q; Yu M; Patel H; Zhang X; Wang L; Grabner M
    BMJ Open Diabetes Res Care; 2019; 7(1):e000884. PubMed ID: 31875137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Perioperative HbA1c on Reimbursements in Diabetes Mellitus Patients Undergoing Total Hip Arthroplasty: A Nationwide Analysis.
    Kurowicki J; Rosas S; Khlopas A; Newman JM; Law TY; Roche MW; Higuera CA; Mont MA
    J Arthroplasty; 2018 Jul; 33(7):2038-2042. PubMed ID: 29891083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study.
    Buysman EK; Liu F; Hammer M; Langer J
    Adv Ther; 2015 Apr; 32(4):341-55. PubMed ID: 25832470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.
    Cranor CW; Bunting BA; Christensen DB
    J Am Pharm Assoc (Wash); 2003; 43(2):173-84. PubMed ID: 12688435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of Metabolic Control and Diabetes Management in Insulin-Treated Patients Results in Substantial Cost Savings for the German Health System.
    Fritzen K; Gutschek B; Coucke B; Zakrzewska K; Hummel M; Schnell O
    J Diabetes Sci Technol; 2018 Sep; 12(5):1002-1006. PubMed ID: 29436251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis.
    Cheng SW; Wang CY; Chen JH; Ko Y
    Medicine (Baltimore); 2018 Aug; 97(31):e11602. PubMed ID: 30075532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes.
    Anjana RM; Kesavadev J; Neeta D; Tiwaskar M; Pradeepa R; Jebarani S; Thangamani S; Sastry NG; Brijendra Kumar S; Ramu M; Gupta PPK; Vignesh J; Chandru S; Kayalvizhi S; Jagdish PS; Uthra SCB; Lovelena M; Jyoti S; Suguna Priya S; Kannan A; Mohan V; Unnikrishnan R
    Diabetes Technol Ther; 2017 Sep; 19(9):533-540. PubMed ID: 28930495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world cost-effectiveness: lower cost of treating patients to glycemic goal with liraglutide versus exenatide.
    DeKoven M; Lee WC; Bouchard J; Massoudi M; Langer J
    Adv Ther; 2014 Feb; 31(2):202-16. PubMed ID: 24477354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality improvement and cost reduction realized by a purchaser through diabetes disease management.
    Snyder JW; Malaskovitz J; Griego J; Persson J; Flatt K
    Dis Manag; 2003; 6(4):233-41. PubMed ID: 14736347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preadmission glycemic control and changes to diabetes mellitus treatment regimen after hospitalization.
    Bergenstal RM; Fahrbach JL; Iorga ŞR; Fan Y; Foster SA
    Endocr Pract; 2012; 18(3):371-5. PubMed ID: 22548941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemoglobin A1c and Permissive Hyperglycemia in Patients in the Intensive Care Unit with Diabetes.
    Balintescu A; Mårtensson J
    Crit Care Clin; 2019 Apr; 35(2):289-300. PubMed ID: 30784610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR; Hagan MA
    Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Utility of Laparoscopic Roux-en-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes and Obesity with a BMI ≥ 27.5 kg/m2: a Multi-Center Study with a 4-Year Follow-Up of Surgical Cohort.
    Tu Y; Wang L; Wei L; Xu Y; Han X; Han J; Yu H; Zheng C; Bao Y; Jia W
    Obes Surg; 2019 Dec; 29(12):3978-3986. PubMed ID: 31338737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a Diabetes Self-Management Program: Claims Analysis on Comorbid Illnesses, Health Care Utilization, and Cost.
    Turner RM; Ma Q; Lorig K; Greenberg J; DeVries AR
    J Med Internet Res; 2018 Jun; 20(6):e207. PubMed ID: 29934284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens.
    Xie L; Wei W; Pan C; Du J; Baser O
    Adv Ther; 2011 Nov; 28(11):1000-11. PubMed ID: 22038703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
    Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
    Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.